Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group Inc. announced the resignation of Mr. Yu Xiong, a non-executive director, effective from 14 October 2024. His departure, due to work adjustment, is amicable with no disagreements or concerns for shareholders. The company will promptly hold a re-election for his successor in compliance with legal and internal guidelines.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
